These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 24437226

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Use of serological markers in the diagnosis and prognosis of chronic viral hepatitis].
    Valdovinos Díaz MA, Páez Rodríguez O, Galván Guerra E, Wolpert E.
    Rev Invest Clin; 1985; 37(4):373-83. PubMed ID: 3006201
    [No Abstract] [Full Text] [Related]

  • 3. High incidence of hepatocellular carcinoma in ESRD patients: caused by high hepatitis rate or 'uremia'? a population-based study.
    Hwang JC, Weng SF, Weng RH.
    Jpn J Clin Oncol; 2012 Sep; 42(9):780-6. PubMed ID: 22782961
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Viral hepatitis and hepatocellular carcinoma.
    Sallie R, Di Bisceglie AM.
    Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
    [Abstract] [Full Text] [Related]

  • 6. Chronic hepatitis B and hepatocellular carcinoma.
    McClune AC, Tong MJ.
    Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
    [Abstract] [Full Text] [Related]

  • 7. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK, HEPNET. Greece Cohort Study Group.
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [Abstract] [Full Text] [Related]

  • 8. [Optimal antiviral therapy of chronic hepatitis caused by hepatitis C virus].
    Cooreman MP, Stadhouders P.
    Orv Hetil; 1997 Jun 01; 138(22 Suppl 1):1476-82. PubMed ID: 9221377
    [Abstract] [Full Text] [Related]

  • 9. Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy.
    Gonzalez SA, Keeffe EB.
    Front Biosci (Landmark Ed); 2011 Jan 01; 16(1):225-50. PubMed ID: 21196168
    [Abstract] [Full Text] [Related]

  • 10. Hepatocellular carcinoma and hepatitis C in the United States.
    El-Serag HB.
    Hepatology; 2002 Nov 01; 36(5 Suppl 1):S74-83. PubMed ID: 12407579
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E, Bergk A, Berg T.
    Z Gastroenterol; 2008 Jan 01; 46(1):69-80. PubMed ID: 18188819
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatitis C virus infection and hepatocellular carcinoma.
    Blonski W, Reddy KR.
    Clin Liver Dis; 2008 Aug 01; 12(3):661-74, x. PubMed ID: 18625433
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.